Pfizer–BioNTech COVID-19 vaccine - Wikipedia
WEBThe Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
Pfizer and BioNTech Provide Update on mRNA-based …
WEBAug 16, 2024 · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals 18-64 years of age. The ...
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBAug 23, 2021 · The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and; provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
Pfizer and BioNTech Announce Further Details on …
WEBApr 9, 2020 · Pfizer and BioNTech to jointly develop COVID-19 vaccine, initially in the United States and Europe, and scale-up manufacturing capacity to support global supply
Pfizer-BioNTech COVID-19 Vaccine | FDA
WEBSep 11, 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19. The Pfizer-BioNTech...
Pfizer COVID-19 Vaccine Summary | Vaccines & Immunizations
WEBAug 28, 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL …
The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you …
WEBAug 18, 2022 · This article provides a summary of the interim recommendations for the use of the Pfizer BioNTech (BNT162b2) vaccine against COVID-19 issued by WHO Strategic Advisory Group of Experts on Immunization (SAGE).
FDA Approves First COVID-19 Vaccine
WEBThe vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16...
WEBAug 22, 2024 · The Pfizer-BioNTech COVID-19 Vaccine is a vaccine for use in individuals 6 months through 11 years of age to prevent COVID-19. The FDA has authorized the emergency use of the Pfizer-BioNTech...
Health Canada approves Pfizer-BioNTech's updated COVID-19 …
WEB11 hours ago · Health Canada has approved Pfizer-BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The mRNA vaccine, called Comirnaty, targets ...